| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |